ARTICLE
|
doi:10.20944/preprints202110.0121.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
botulinum toxin; subtype A2; clinical tolerability; safety
Online: 7 October 2021 (15:02:29 CEST)
REVIEW
|
doi:10.20944/preprints202211.0177.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Real-world; Erenumab; Galcanezumab; Fremanezumab; Eptinezumab; pharmacoepidemiology; effectiveness; tolerability; safety; treatment pause; switching
Online: 9 November 2022 (11:51:21 CET)